Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec;38(6):2445-2450.
doi: 10.1007/s10792-017-0750-9. Epub 2017 Oct 25.

Elevated serum fetuin-A levels are associated with grades of retinopathy in type 2 diabetic patients

Ahu Yilmaz  1 , Tolga Yilmaz  2 , Murat Gunay  3
Affiliations

Elevated serum fetuin-A levels are associated with grades of retinopathy in type 2 diabetic patients

Ahu Yilmaz et al. Int Ophthalmol. 2018 Dec.

Abstract

Purpose: Fetuin-A is a physiological inhibitor of insulin receptor tyrosine kinase and thus associated with insulin resistance, metabolic syndrome, and an increased risk for type 2 diabetes mellitus (T2DM). This study aims to investigate the possible relation between the serum fetuin-A levels and the stages of diabetic retinopathy (DR) in patients with T2DM.

Methods: This prospective study included 82 patients with T2DM and 19 age- and gender-matched healthy controls (HCs) (group 1). Diabetic patients were subclassified into three groups according to ocular findings: without DR (group 2; n = 26); non-proliferative DR (group 3; n = 29), and proliferative DR (group 4; n = 27). Serum fetuin-A levels were determined by a spectrophotometric technique using an immulite chemiluminescent immunometric assay. The data were analyzed using a Mann-Whitney U test, and the results were expressed as mean ± standard deviation.

Results: Mean fetuin-A values were 256.4 ± 21.3 μg/ml in group 1, 263.5 ± 24.2 μg/ml in group 2, 282.2 ± 31.1 μg/ml in group 3, and 296.3 ± 26.2 μg/ml in group 4. Group 2 had higher mean fetuin-A level compared with group 1, but the difference was not statistically significant (p > 0.05). Serum fetuin-A levels were significantly higher in groups 3 and 4 compared with HCs (both p < 0.05). Compared with group 2, both DR groups had higher fetuin-A levels with a significant difference (both p < 0.05); and patients with proliferative DR had significantly higher serum fetuin-A levels compared with non-proliferative DR (p < 0.05). The mean serum fetuin-A levels increased with the stage of DR, and the highest levels were found in patients with proliferative DR.

Conclusion: Our findings suggest an association between fetuin-A levels and DR stage. In diabetic patients, the risk of retinopathy development increases with higher fetuin-A values. Fetuin-A may play an important role in the pathophysiology and progression of DR.

Keywords: Diabetic retinopathy; Fetuin-A; Insulin resistance; Type 2 diabetes mellitus.

PubMed Disclaimer

References

    1. Diabetes. 2008 Oct;57(10):2762-7 - PubMed
    1. Cardiovasc Diabetol. 2010 Sep 07;9:48 - PubMed
    1. Metabolism. 2010 Jun;59(6):873-8 - PubMed
    1. Biochem J. 2003 Nov 15;376(Pt 1):135-45 - PubMed
    1. Diabet Med. 2008 Jan;25(1):45-50 - PubMed

Substances

LinkOut - more resources